This week marked a decline in executive appointments across the forex, crypto, and fintech sectors, suggesting a slight reduction in industry transitions.Recently, the financial...
Wondering what IP developments took place last week? Look no further as we present to you the SpicyIP Weekly Review, highlighting the discussions that...
ARTICLE | DealsPlus: Everest takes local rights to Kezar’s lupus nephritis treatment, and updates from Celexor, GSK, Jura, Syena, Moucellion and Xungene By BioCentury Staff
September...
UK oil engineering company Wood Group raised its full-year revenue and earnings expectations on Tuesday after winning a series of new contracts, even as...
The Food and Drug Administration on Monday approved a vaccine to prevent respiratory syncytial virus infections in infants during their first few months of...
Dive Brief:
Moderna on Thursday said the updated COVID shot it's preparing ahead of a fall vaccination campaign can neutralize two new coronavirus strains, among...
ARTICLE | RegulationPlus: Atreca scraps lead program, turns to ADCs and updates from ALX Oncology, Hansoh-Antengene, Foghorn, Galera, Cascade By BioCentury Staff
August 12, 2023...
ARTICLE | Management TracksPlus: Quirk takes on CEO role at Terns and an update from Structure By Richard Guy, Biopharma Analyst, and Gunjan Ohri, Data...
GSK on Thursday was cleared to broaden use of its cancer immunotherapy Jemperli, winning approval from the Food and Drug Administration to market the...
European life sciences investment firm Medicxi on Thursday said it raised $400 million, becoming the latest biotech-focused venture firm to boost its capital reserves...
